ursolic acid has been researched along with licochalcone a in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheon, SH; Kim, SN; Lee, W; Yoon, G | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cheon, SH; Kim, SN; Lee, W; Liu, Z; Yoon, G | 1 |
Cui, Z; Ji, S; Kuang, Y; Li, K; Lin, Y; Qiao, X; Song, W; Tang, S; Ye, M; Yu, S | 1 |
Kuang, Y; Li, K; Lin, Y; Qiao, X; Sabir, G; Song, W; Wang, S; Ye, M | 1 |
Cao, Y; Chen, H; Cheon, SH; Liu, Z; Su, Y; Wu, C; Yoon, G; Zhao, Y; Zheng, S; Zhu, W; Zhuang, F | 1 |
Deng, Y; Li, CH; Wu, T; Zhai, SQ | 1 |
1 review(s) available for ursolic acid and licochalcone a
Article | Year |
---|---|
Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Female; Humans; Pregnancy; Toxoplasma; Toxoplasmosis | 2019 |
6 other study(ies) available for ursolic acid and licochalcone a
Article | Year |
---|---|
Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B.
Topics: Chalcones; Glycyrrhiza; Plant Extracts; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Bromine; Chalcones; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship | 2011 |
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
Topics: Animals; Antioxidants; Drug Screening Assays, Antitumor; Glycyrrhiza; Hep G2 Cells; Humans; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Monophenol Monooxygenase; NF-kappa B; Nitric Oxide; Phenols; Plant Roots; Plants, Medicinal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rhizome | 2017 |
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biological Products; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glycyrrhiza; HEK293 Cells; Hep G2 Cells; Humans; Lipopolysaccharides; Macrophages; MCF-7 Cells; Mice; Monophenol Monooxygenase; NF-kappa B; Plant Roots; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RAW 264.7 Cells; Small Molecule Libraries | 2017 |
Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors.
Topics: Allyl Compounds; Animals; Chalcones; Enzyme Inhibitors; Hep G2 Cells; Humans; Male; Mice; Molecular Docking Simulation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Quantitative Structure-Activity Relationship; Rats, Sprague-Dawley | 2019 |